Regular Article
Interleukin-6 Negatively Regulates the Expression of Pregnane X Receptor and Constitutively Activated Receptor in Primary Human Hepatocytes

https://doi.org/10.1006/bbrc.2000.3219Get rights and content

Abstract

The marked impairment of hepatic drug metabolism during inflammation and infections has been known for many years and shown to result from down-regulation of cytochrome P450s (CYP) by cytokines. However, the mechanism of this repression is unknown. Using primary cultures of human hepatocytes, we show here that interleukin-6 (IL-6) rapidly and markedly decreases the expression of PXR (pregnane X receptor) and CAR (constitutively activated receptor) mRNAs, but does not affect the levels of dioxin receptor and glucocorticoid receptor mRNA. In parallel, IL-6 decreases both rifampicin- and phenobarbital-mediated induction of CYP2B6, CYP2C8, CYP2C9, and CYP3A4. As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays, our data suggest that the loss of CYP2 and CYP3 inducibility results from the negative regulation of PXR and CAR gene expression by this cytokine.

References (33)

  • Y.C. Zhou et al.

    STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain

    J. Biol. Chem.

    (1999)
  • H.S. Choi et al.

    Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR

    J. Biol. Chem.

    (1997)
  • P. Delerive et al.

    Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1

    J. Biol. Chem.

    (1999)
  • F.P. Guengerich et al.

    Activation of mutagens by human cytochrome P-450 enzymes [discussed]

    Prog. Clin. Biol. Res.

    (1990)
  • F.P. Guengerich et al.

    Activation of carcinogens by human liver cytochromes P-450

    Basic Life Sci.

    (1990)
  • S.M. Moochhala

    Alteration of drug biotransformation by interferon and host defence mechanism

    Ann. Acad. Med. Singapore

    (1991)
  • Cited by (214)

    • PXR as the tipping point between innate immune response, microbial infections, and drug metabolism

      2022, Biochemical Pharmacology
      Citation Excerpt :

      Consequently, NFkB suppression of PXR signaling results in decreased CYP expression and biotransformation [10]. Proinflammatory cytokines, particularly interleukin (IL) 6, have been shown to inhibit the induction of CYP2B6, CYP2C8/9, and CYP3A4 by PXR agonists such as rifampicin and phenobarbital, while reducing PXR mRNA levels [21]. Additionally, inhibition of PXR activation by way of its phosphorylation can be modulated by NFkB-mediated inflammation.

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: 33-4-6752 3681. E-mail: [email protected].

    View full text